NXC Financials | Income, Balance Sheet & Cash Flow

The financial statements for NXC (NXC) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.

See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.

Financial Statements

Related peers

Compare More →
C
Citigroup Inc.
$129.65
+2.67%
BMHL
Bluemount Holdings Limited
$3.51
-3.39%
NXN
Nuveen New York Select Tax-Free Income Portfolio
$12.14
+0.58%
OFS
OFS Capital Corporation
$4.08
+7.37%
GECC
Great Elm Capital Corp.
$5.22
+1.36%
A
Agilent Technologies, Inc.
$120.40
+2.47%

Frequently Asked Questions

What are NXC's latest financial results?

Review NXC's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.

How has NXC's revenue and net income changed over time?

Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.

What is NXC's cash flow situation and liquidity?

Cash flow statements reveal how NXC generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.

How does NXC's financial performance compare to industry peers?

Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether NXC is outperforming or lagging within its sector.

Are NXC's financial statements showing sustainable profitability?

By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether NXC's profits are repeatable and supported by strong fundamentals.